Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 12660339)

Published in J Am Soc Nephrol on April 01, 2003

Authors

Kelly D Smith1, Lucile E Wrenshall, Roberto F Nicosia, Raimund Pichler, Christopher L Marsh, Charles E Alpers, Nayak Polissar, Connie L Davis

Author Affiliations

1: Department of Pathology, University of Washington Medical Center, Seattle, Washington , USA.

Articles by these authors

VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45

The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19

The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77

Mouse models of diabetic nephropathy. J Am Soc Nephrol (2009) 3.74

Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60

Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: a multicenter, prospective, randomized trial. Ann Surg (2006) 3.34

C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85

Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol (2007) 2.66

Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42

Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int (2005) 2.39

TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol (2008) 2.23

Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int (2004) 2.21

BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol (2010) 2.16

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14

Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development. Nat Immunol (2007) 2.08

Implementing practical interventions to support chronic illness self-management. Jt Comm J Qual Saf (2003) 2.08

Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int (2003) 2.03

WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med (2011) 1.91

West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84

Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol (2003) 1.84

Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology (2006) 1.80

Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest (2007) 1.77

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76

A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol (2007) 1.74

Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int (2005) 1.74

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69

Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol (2003) 1.68

Timing of surgery in cauda equina syndrome with urinary retention: meta-analysis of observational studies. J Neurosurg Spine (2008) 1.65

Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging (2002) 1.59

Kidney transplant chains amplify benefit of nondirected donors. JAMA Surg (2013) 1.52

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52

The aortic ring model of angiogenesis. Methods Enzymol (2008) 1.51

Endovenous laser treatment of the small [corrected] saphenous vein: efficacy and complications. J Vasc Surg (2007) 1.50

Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging. Int J Cardiovasc Imaging (2006) 1.50

Effects of cyclosporine in osteopontin null mice. Kidney Int (2002) 1.47

De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol (2009) 1.45

Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase. Immunol Cell Biol (2011) 1.45

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol (2008) 1.45

Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol (2004) 1.41

Regional manifestations and control of the immune system. FASEB J (2002) 1.38

Renal injury in apolipoprotein E-deficient mice. Lab Invest (2002) 1.36

Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol (2003) 1.35

Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol (2005) 1.33

The economic burden of carpal tunnel syndrome: long-term earnings of CTS claimants in Washington State. Am J Ind Med (2007) 1.32

Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol (2003) 1.31

Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol (2013) 1.30

MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging (2011) 1.29

A new function for parietal epithelial cells: a second glomerular barrier. Am J Physiol Renal Physiol (2009) 1.29

Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis (2003) 1.28

Pathology of human diabetic nephropathy. Contrib Nephrol (2011) 1.26

The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting. Angiogenesis (2003) 1.25

Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol (2014) 1.24

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos (2006) 1.22

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol (2011) 1.18

Optical microangiography of retina and choroid and measurement of total retinal blood flow in mice. Biomed Opt Express (2012) 1.18

Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J Am Soc Nephrol (2004) 1.15

Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins. J Cell Sci (2003) 1.15

Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol (2009) 1.15

Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol (2010) 1.13

Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol (2012) 1.13

Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One (2012) 1.12

Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol (2009) 1.11

Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature. Clin J Am Soc Nephrol (2007) 1.10

Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation (2007) 1.09

Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J Virol (2008) 1.08

Patterns of glomerular injury in kidneys infiltrated by lymphoplasmacytic neoplasms. Hum Pathol (2011) 1.06

In vitro metabolism of cyclosporine A by human kidney CYP3A5. Biochem Pharmacol (2004) 1.06

Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J Am Soc Nephrol (2010) 1.06

Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem (2011) 1.04

Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One (2009) 1.03

Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens (2005) 1.02

Determination of colonoscopy indication from administrative claims data. Med Care (2014) 1.01

Interrater reliability of posture observations. Hum Factors (2009) 1.01

Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant (2004) 1.00

Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation (2002) 1.00

Noninvasive imaging of retinal morphology and microvasculature in obese mice using optical coherence tomography and optical microangiography. Invest Ophthalmol Vis Sci (2014) 1.00

Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J Immunol (2013) 0.99

Iatrogenic phospholipidosis mimicking Fabry disease. Am J Kidney Dis (2006) 0.99

Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. J Histochem Cytochem (2006) 0.99

Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. Kidney Int (2011) 0.98

Asian American and Pacific Islander seafood consumption -- a community-based study in King County, Washington. J Expo Anal Environ Epidemiol (2003) 0.98

Regulation of angiogenesis by macrophages, dendritic cells, and circulating myelomonocytic cells. Curr Pharm Des (2009) 0.98

Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice. Am J Nephrol (2003) 0.98

Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J Am Soc Nephrol (2008) 0.97

The angiogenic response of the aorta to injury and inflammatory cytokines requires macrophages. J Immunol (2008) 0.96

Novel siRNA delivery system to target podocytes in vivo. PLoS One (2010) 0.96

Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest (2009) 0.96

Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology (2006) 0.96

Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia. J Bone Miner Res (2013) 0.96

Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem (2003) 0.95

SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab Invest (2012) 0.95

Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis (2004) 0.95

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics (2008) 0.95

Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors. Pharmacogenetics (2003) 0.95